24, 3%, 57, 5%) и GPIIb/ IIIa инхибитори (RRR = 18, 2%; CI:
Klopidogreeli kasutamine CURE- uuringus seostus trombolüütilise ravi (RRR=43, 3%; CI: 24, 3%, 57, 5%) ja GPIIb/ IIIa inhibiitorite (RRR=18, 2%; CI: